Themis Medicare's Q2 FY 2025-26 Quarterly Results
- 16 Nov 2025
Result Summary
- Themis Medicare Ltd reported a 17.7% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Sep (Q2 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a decline of 31.2%.
- Its expenses for the quarter were down by 23.3% QoQ and 17.5% YoY.
- The net profit decreased 74.5% QoQ and decreased 125.3% YoY.
- The earnings per share (EPS) of Themis Medicare Ltd declined at 0.39 during Q2 FY 2025-26.
Financial Statments for Q2 FY 2025-26
Total Income | 81.23 | 98.75 | 118.15 | -17.7% | -31.2% |
Total Expenses | 86.41 | 112.68 | 104.77 | -23.3% | -17.5% |
Profit Before Tax | -5.19 | -13.93 | 13.37 | -62.7% | -138.8% |
Tax | 0.16 | 0.16 | 3.50 | 0.0% | -95.4% |
Profit After Tax | -3.62 | -14.22 | 14.29 | -74.5% | -125.3% |
Earnings Per Share | -0.39 | -1.54 | 1.55 | -74.7% | -125.2% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Themis Medicare Ltd is a pharmaceutical company known for its focus on the development and marketing of pharmaceutical products. The company operates in the healthcare industry, providing a range of therapeutic solutions with a particular emphasis on innovative treatments. It caters to both domestic and international markets. Recent developments or strategic shifts in the company's operations are not available in the current dataset, and thus are not included in this overview.
Revenue
In the second quarter of fiscal year 2026 (Q2FY26), Themis Medicare Ltd reported a total income of ₹81.23 crores. This represents a decline from the ₹98.75 crores recorded in the first quarter of fiscal year 2026 (Q1FY26), marking a quarter-over-quarter (QoQ) decrease of 17.7%. Compared to the second quarter of fiscal year 2025 (Q2FY25), where total income was ₹118.15 crores, there is a year-over-year (YoY) decrease of 31.2%. This significant reduction in revenue over both periods is noted in the financial data provided.
Profitability
The company experienced a loss in profitability during Q2FY26, as evidenced by the negative profit before tax (PBT) of ₹-5.19 crores. This is an improvement from the previous quarter's PBT of ₹-13.93 crores, which results in a QoQ improvement of 62.7%. However, when compared to Q2FY25, when the company had a positive PBT of ₹13.37 crores, there is a YoY decrease of 138.8%. The tax expense remained constant at ₹0.16 crores from the previous quarter, showing a 0.0% change QoQ. The profit after tax (PAT) for Q2FY26 was ₹-3.62 crores, showing a reduction in losses QoQ by 74.5% from ₹-14.22 crores in Q1FY26. Compared to the profit of ₹14.29 crores in Q2FY25, PAT decreased by 125.3% YoY.
Operating Metrics
The earnings per share (EPS) for Themis Medicare Ltd in Q2FY26 was ₹-0.39, which is an improvement from the previous quarter's EPS of ₹-1.54, marking a QoQ increase of 74.7%. However, compared to Q2FY25, where the EPS was ₹1.55, there is a YoY decrease of 125.2%. Total expenses for Q2FY26 stood at ₹86.41 crores, a reduction from ₹112.68 crores in Q1FY26, showing a QoQ decrease of 23.3%. When compared to Q2FY25's expenses of ₹104.77 crores, there is a YoY decrease of 17.5%. These figures highlight the significant changes in the company's operational costs over the comparative periods.